Roivant Sciences financial statements
로이반트 사이언시스NASDAQ:ROIV · Nasdaq · Healthcare$35.72+0.62%
2026-10-02 closeRoivant Sciences's published financial data is dated 2026-10-04. 2025 revenue was $29M. 2025 operating profit was −$1B.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy